In this podcast episode, we discuss the journey of novel modalities in rare disease treatment to patients, particularly advancements in oncology and the increasing role of patients' families in ...
The CNPV pilot program significantly reduces review times, but may challenge safety standards and resource allocation.
Gain leadership and innovation insights from CEO of the Year finalist at 2025 CPHI Pharma Awards, Mahler Hanns-Christian, who ...
Unlock the potential of high-purity methylcellulose in biotech. Join our upcoming webinar to explore how METHONOVA™ enhances ...
AI transforms formulation, bioanalysis, and manufacturing; accelerated FDA reviews demand parallel development readiness; new nasal spray enhances patient drug access. In this PharmTech video feature, ...
FDA will convene a one-day, in-person and virtual public workshop, “Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine ,” on Tuesday, Dec. 16, 2025 (1). The workshop is ...
Darrin Lang is CEO, LABUR. Larry Egan is Vice President of Strategic Technologies, Alnylam Pharmaceuticals Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback